Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival

Colorectal carcinoma (CRC) is one of the most common carcinomas worldwide. Early detection is crucial for reducing morbidity and mortality. Several promising studies described the use of midkine (MK) as a tumor marker. This study aimed to investigate a larger collective to ascertain if the preoperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemper, Marius, Hentschel, Wiebke, Graß, Julia‐Kristin, Stüben, Bjoern‐Ole, Konczalla, Leonie, Rawnaq, Tamina, Ghadban, Tarik, Izbicki, Jakob R., Reeh, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064087/
https://www.ncbi.nlm.nih.gov/pubmed/31984657
http://dx.doi.org/10.1002/cam4.2884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064087/
https://www.ncbi.nlm.nih.gov/pubmed/31984657
http://dx.doi.org/10.1002/cam4.2884

Ejemplares similares